Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

123.47 -0.45 (-0.36%)
Streaming Delayed Price Updated: 10:41 AM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
From Teleflex Incorporated
Via GlobeNewswire
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Retirement Stocks
How Is The Market Feeling About Teleflex?
 
Via Benzinga
Earnings Scheduled For May 1, 2025
 
Via Benzinga
Teleflex Publishes 2024 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
TFX Q1 Earnings Call: Guidance Cut and Strategic Shifts Dominate Amid Tariff Headwinds
Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9%... 
Via StockStory
Topics Economy World Trade
New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Q1 Earnings Highlights: Teleflex (NYSE:TFX) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
Teleflex (NYSE:TFX) Reports Q1 In Line With Expectations
Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9%... 
Via StockStory
Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook
From Teleflex Incorporated
Via GlobeNewswire
TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Teleflex to Present at the BofA Securities 2025 Health Care Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
From Teleflex Incorporated
Via GlobeNewswire
What To Expect From Teleflex’s (TFX) Q1 Earnings
Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation – TFX
From Rosen Law Firm
Via Business Wire
1 Cash-Producing Stock Worth Your Attention and 2 to Think Twice About
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting
Experienced Urologists to Present Latest Findings and Host Multiple Educational Sessions 
From Teleflex Incorporated
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Don't overlook TELEFLEX INC (NYSE:TFX)—it's a hidden gem with strong fundamentals and an attractive price tag.
TELEFLEX INC has a stellar value proposition. NYSE:TFX not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Announces First Quarter 2025 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in... 
Via StockStory
Topics Artificial Intelligence Economy
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
3 Reasons TFX is Risky and 1 Stock to Buy Instead
Shareholders of Teleflex would probably like to forget the past six months even happened. The stock dropped 45.4% and now trades at $128.98. This was partly driven by its softer quarterly results and... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.